CTIS.eu › Cities › Norway › Loerenskog
Loerenskog
Norway
115 total trials
47 recruiting
2022-502437-25-00
4
2022-08-15
advanced or metastatic non-small cell lung cancer
2023-509569-19-00
10
2022-08-10
venous thromboembolism (VTE)
2024-511560-93-00
5
2022-03-29
Schizophrenia
2023-503571-19-00
5
2022-01-20
Chronic Obstructive Pulmonary Disease (COPD)
2023-507688-20-00
5
2021-12-03
Participants with completely resected Stage III or Stage IV melanoma
2024-511043-25-00
5
2021-11-30
Colorectal Cancer
2022-500385-99-00
5
2021-06-03
SARS-CoV II infection (Coronavirus disease)
2023-506919-18-00
5
2021-05-17
Mild cognitive impairment (MCI) or mild dementia, both of the Alzheime
2024-512012-21-00
5
2021-04-08
Chronic Obstructive Pulmonary Disease
2023-508443-40-00
5
2020-12-18
Lung Cancer, Non-Small Cell
2023-507669-24-00
5
2019-11-05
Chronic lymphocytic leukemia
2024-513762-18-00
4
2019-09-20
Primary Biliary Cholangitis (PBC)
2023-503956-29-00
5
2019-08-26
Microsatellite Instability High (MSI-H) or Mismatch Repair Deficient
M
2024-512158-12-00
5
2018-12-14
Bladder Cancer
Muscle-Invasive Bladder Cancer
2023-510200-42-00
5
2017-12-06
primary sclerosing cholangitis (PSC)
2023-510557-42-00
4
2017-07-10
chronic lymphocytic leukemia
2022-501784-40-00
5
2017-05-26
Untreated Unresectable or Metastatic Urothelial Cancer
2023-509092-16-00
4
Chronic myelomonocyte leukemia
2023-509472-42-00
5
Relapsed and/or
Refractory Multiple Myeloma
Showing 97–115 of 115 trials